Literature DB >> 11801889

Biliary atresia: an update on our understanding of the disorder.

M R Narkewicz1.   

Abstract

Biliary atresia is the leading cause of cholestasis in infants younger than 3 months. It is also the leading indication for liver transplantation in children. This review focuses on recent advances in the etiology, diagnosis, and management of biliary atresia.

Entities:  

Mesh：

Year:  2001        PMID： 11801889     DOI： 10.1097/00008480-200110000-00009

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN： 1040-8703            Impact factor:   2.856


  5 in total

1.  There is no association between K469E ICAM-1 gene polymorphism and biliary atresia.

Authors:  Paisarn Vejchapipat; Naruemol Jirapanakorn; Nutchanart Thawornsuk; Apiradee Theamboonlers; Voranush Chongsrisawat; Soottiporn Chittmittrapap; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

2.  Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease.

Authors:  Erik S Barton; Bryan E Youree; Daniel H Ebert; J Craig Forrest; Jodi L Connolly; Tibor Valyi-Nagy; Kay Washington; J Denise Wetzel; Terence S Dermody
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

3.  Relationship between hepatic CTGF expression and routine blood tests at the time of liver transplantation for biliary atresia: hope or hype for a biomarker of hepatic fibrosis.

Authors:  Allah Haafiz; Christian Farrington; Joel Andres; Saleem Islam
Journal:  Clin Exp Gastroenterol       Date:  2011-04-20

4.  Immunohistochemical localization of transforming growth factor β-1 and its relationship with collagen expression in advanced liver fibrosis due to biliary atresia.

Authors:  Christian Farrington; Don Novak; Chen Liu; Allah B Haafiz
Journal:  Clin Exp Gastroenterol       Date:  2010-12-09

5.  Clinical benefit of liver stiffness measurement at 3 months after Kasai hepatoportoenterostomy to predict the liver related events in biliary atresia.

Authors:  Seung Min Hahn; Seung Kim; Kook In Park; Seok Joo Han; Hong Koh
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.